Azithromycin stops bacteria from multiplying by blocking their ability to make essential proteins. It enters the bacterial cell and binds tightly to the 50S ribosomal subunit, the cellular machinery responsible for assembling proteins. By blocking the exit tunnel for the growing peptide chain, it halts protein synthesis, which stops bacterial growth and allows the patient's immune system to clear the infection. Because it concentrates heavily inside human cells—particularly macrophages and neutrophils—it is exceptionally effective against intracellular 'atypical' pathogens like Chlamydia and Legionella that hide from other antibiotics.
Derived from erythromycin A, a natural product of the actinomycete Saccharopolyspora erythraea. Azithromycin was created by inserting a methyl-substituted nitrogen atom into the lactone ring of erythromycin A, transforming the 14-membered lactone ring into a 15-membered ring (an azalide).
In the late 1970s, researchers at the pharmaceutical company Pliva in Zagreb, Croatia (then part of Yugoslavia), led by Slobodan Đokić, were experimenting with erythromycin to improve its acid stability and pharmacokinetic profile. In 1980, they successfully synthesized azithromycin, the first member of a new subclass of macrolides called azalides. Pliva patented the compound and subsequently signed a licensing agreement with Pfizer in 1986 for global markets outside of Central and Eastern Europe. Pfizer launched the drug under the brand name Zithromax in 1991. Its unique pharmacokinetic profile—characterized by rapid tissue penetration and an extraordinarily long half-life—revolutionized antibiotic prescribing by allowing for short-course therapies like the famous 'Z-Pak'. It quickly became one of the best-selling antibiotics globally and remains on the World Health Organization (WHO) Model List of Essential Medicines.
Developed and initially studied for respiratory tract infections and skin or soft tissue infections to overcome the gastrointestinal side effects and frequent dosing requirements of erythromycin.